Titlebook: Bioactivity of Engineered Nanoparticles; Bing Yan,Hongyu Zhou,Jorge L. Gardea-Torresdey Book 2017 Springer Nature Singapore Pte Ltd. 2017

antecedence

Nanomaterials in Cancer Theranostics,w imaging techniques and therapeutic approaches, several nanomaterials have demonstrated great theranostic potential in image-guided therapy of diseases, especially in cancer therapy. In this review, the current status and perspective of nanoparticles in the development of cancer theranostic agents

ORE

Pluronic Nanotechnology for Overcoming Drug Resistance,ective treatment strategies. We include the role of Pluronic polymers as a pharmaceutic excipient and drug delivery vehicle in this review. In addition, we highlight examples of Pluronic nanosystems that are currently in preclinical development, clinical trials, and clinically translatable formulati

effrontery

AWL

Experimental Research into Metallic and Metal Oxide Nanoparticle Toxicity In Vivo,e noxious as compared with their fine micrometric counterparts although physiological mechanisms of their elimination from lungs proved highly active. At the same time, the in situ cytotoxicity, organ-systemic toxicity and in vivo genotoxicity of Me-NPs having a given geometry strongly depends on th

集合

Bing Yan,Hongyu Zhou,Jorge L. Gardea-TorresdeyProvides a comprehensive understanding of the biomedical applications and toxicity of engineered nanoparticles.Describes the methodologies used to assess the bioactivity of engineered nanoparticles.Pr

懶惰人民

慌張

Bioactivity of Engineered Nanoparticles978-981-10-5864-6Series ISSN 2194-0452 Series E-ISSN 2194-0460

insincerity

https://doi.org/10.1007/978-981-10-5864-6Engineered nanoparticles; Nanomaterial biomolecules interaction; Nanotoxicology assessments; Nanopartic

overshadow

978-981-13-5510-3Springer Nature Singapore Pte Ltd. 2017

cavity